Nyse jnj compare.

... (NYSE:JNJ) Compare. Johnson & Johnson logo. Johnson & Johnson. 32. 5. NYSE:JNJ (USA) Ordinary Shares. $ 152.50 -0.3 (-0.2%) 10:08 PM EST.

Nyse jnj compare. Things To Know About Nyse jnj compare.

Johnson & Johnson (JNJ-0.80%) announced last year that it would be spinning off its consumer health business. The separation, which could take as long as 24 months to complete, will leave ...Stock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Johnson & Johnson (NYSE: JNJ) has a higher price-to-earnings ratio of 28.61x compared to its average ratio,, and the 36-month beta value for JNJ is at 0.56. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 2 rating it as “overweight,” 14 as “hold,” and 0 as “sell.”. The electric vehicle boom is ...searchCompare to. Pfizer Inc. $29.50. PFE 2.08%. Coca-Cola Co. $58.60. KO ... Johnson & Johnson's (NYSE:JNJ) Revised Earnings Don't Worry Investors - TipRanks.com.Compare Johnson & Johnson (JNJ) to other companies with price, technicals, performance, and fundamentals comparison.

NYSE: JNJ. New Brunswick, New Jersey. $158.38 +3.72 (+2.40%) Share Price. as of December 1 4:00:00 PM EST. About Johnson & Johnson. Johnson & Johnson is a holding company, which engages in the ...6. Johnson & Johnson (NYSE:JNJ) Dividend Yield as of January 16: 2.61%. Johnson & Johnson (NYSE:JNJ) is a New Jersey-based pharmaceutical industry company that offers its DRIP policy to registered ...Nov 8, 2022 · The average PFE stock price target of $51 suggests 8.3% upside potential.Johnson & Johnson (JNJ) StockDespite currency headwinds and higher costs, JNJ topped analysts’ Q3 expectations. JNJ’s ...

JNJ's 3.2% dividend yield clocks in at double the 1.5% yield of the S&P 500 ( SP500 ). The company's 47% EPS payout ratio comes in meaningfully below the 60% EPS payout ratio that is considered ...Johnson & Johnson (NYSE:JNJ) gained in the pre-market trading Tuesday after reporting better than expected financials for Q3 2022, even as the company lowered its full-year revenue outlook amid ...

NYSE: JNJ Johnson & Johnson. Market Cap. $381B. Today's Change (2.40%) $3.72. Current Price. $158.38. ... Although it can be useful when comparing two similar companies, market capitalization and ...JNJ Earnings Date and Information. Johnson & Johnson last announced its quarterly earnings data on October 17th, 2023. The reported $2.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.52 by $0.14. The business had revenue of $21.35 billion for the quarter, compared to analysts' expectations of $21 billion.The 71 analysts offering price forecasts for Johnson & Johnson have a median target of 184.06, with a high estimate of 215.00 and a low estimate of 40.00. The median estimate represents a 86.05 ...J&J’s revenue growth of 7.2% over the last twelve months is much better than -1.7% for Medtronic. Even if we look at a longer time frame, J&J’s sales growth has been better. It rose at an ...Get the latest Exxon Mobil Corp (XOM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Oct 26, 2021 · JNJ is currently trading c.34% higher than the estimated price, hence is overvalued. That being said, JNJ is also known for beating analysts’ estimates. In the last 2 years, JNJ beat analysts ...

1Y. Mkt Cap. P/E. Growth. Strong dividend paying companies in the US market. View Management. Johnson & Johnson (NYSE:JNJ) dividend yield is 3.1%. Dividend payments have increased over the last 10 years and are covered by earnings with a payout ratio of 85.7%.

Comparison Analysis Based on SEC Data. Company Name. Johnson & Johnson. Industry (SIC) 2834 - Pharmaceutical Preparations. Revenue in 2022. $94,943 million (ranked #2 out of 645 companies in the industry) Assets as of 12/31/2022. $187,378 million (ranked #2)Johnson & Johnson (NYSE:JNJ) is a well-liked stock, as evidenced by its price performance over the past 10 years. Its total return is slightly lower than that of the S&P500, but its non-GAAP PE ...Google Finance provides real-time market quotes, international exchanges, up-to-date financial news, and analytics to help you make more informed trading and investment decisions.May 25, 2022 · If JNJ stock closes above 182.50 on the expiration date, the shares will be called away at 182.50, leaving the trader with a total profit of $385 (gain on the shares plus the $300 option premium ... २०२३ अप्रिल ५ ... ... JNJ has been around for over 130 years. Both companies pay growing ... The Dividend Power: Stock Market In Need of a Pullback. Mark Roussin ...Real-time Price Updates for Johnson & Johnson (JNJ-N), along with buy or ... Instrument Name Johnson & Johnson Instrument Symbol (JNJ-N). Instrument Exchange NYSE.

J&J is a member of an elite group of stocks known as Dividend Kings -- S&P 500 companies that have increased their dividend for at least 50 consecutive years. The healthcare giant recently boosted ...J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.The two companies I'll be discussing in this article are longtime dividend payers in the consumer and healthcare industries. Both Procter & Gamble ( PG 0.94%) and Johnson & Johnson ( JNJ -0.20% ...Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. As such, its total long-term debt to capitalization ratio is also higher at 36.9% Vs. J&J’s 27.6%. J&J’s interest coverage in the trailing 12 months is 25.69x, much better than Pfizer’s 9 ...

The stock price of Johnson & Johnson (NYSE: JNJ) reached its all-time high of around $180 just last month before a recent sell-off in pharmaceutical stocks resulted in JNJ falling to $165 levels ...

In this article, we will take a closer look at Johnson & Johnson (NYSE:JNJ) and Pfizer , the two largest US-based pharmaceutical companies by market capitalization. Both are high-quality dividend ...JNJ's 3.2% dividend yield clocks in at double the 1.5% yield of the S&P 500 ( SP500 ). The company's 47% EPS payout ratio comes in meaningfully below the 60% EPS payout ratio that is considered ...NEW BRUNSWICK, N.J., August 23, 2023--Johnson & Johnson (NYSE: JNJ) today announced the final results of its previously announced offer to its shareholders to exchange their shares of Johnson ...150.74. -0.38. -0.25%. Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript October 17, 2023 Operator: Good morning, and welcome to Johnson & Johnson’s Third Quarter 2023 Earnings ...Dec 1, 2023 · JNJ Earnings Date and Information. Johnson & Johnson last announced its quarterly earnings data on October 17th, 2023. The reported $2.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.52 by $0.14. The business had revenue of $21.35 billion for the quarter, compared to analysts' expectations of $21 billion. NEW BRUNSWICK, N.J., MARCH 8, 2023 – Johnson & Johnson (NYSE: JNJ) today announced that Kenvue Inc. (“Kenvue”), a wholly owned subsidiary of Johnson & Johnson, priced an offering of the following series of senior unsecured notes in an aggregate principal amount of $7.75 billion (each series of notes collectively, the “Notes ...

Oct 26, 2021 · JNJ is currently trading c.34% higher than the estimated price, hence is overvalued. That being said, JNJ is also known for beating analysts’ estimates. In the last 2 years, JNJ beat analysts ...

... (NYSE:JNJ) Compare. Johnson & Johnson logo. Johnson & Johnson. 32. 5. NYSE:JNJ (USA) Ordinary Shares. $ 152.50 -0.3 (-0.2%) 10:08 PM EST.

Sundry Photography/iStock Editorial via Getty Images. Johnson & Johnson ( NYSE: JNJ) said Monday that its previously announced offer to shareholders to exchange their shares of JNJ common stock ...NYSE: JNJ. New Brunswick, New Jersey. $158.38 +3.72 (+2.40%) Share Price. as of December 1 4:00:00 PM EST. About Johnson & Johnson. Johnson & Johnson is a holding company, which engages in the ...Analysts expect JNJ’s revenue to increase 2.8% year-over-year to $97.62 billion for the fiscal year ending December 2023. The company’s EPS for the ongoing year is expected to rise 3.6% from the previous year to $10.51. Moreover, JNJ surpassed its consensus EPS estimates in all four trailing quarters, which is impressive.New Brunswick, N.J. (January 26, 2021) – Johnson & Johnson(NYSE: JNJ) today announced results for fourth-quarter and full year 2020. “Our notable full year performance reflects the continued confidence from patients, physicians, customers and consumers in our life-enhancing products and medicines, particularly throughout theApr 18, 2023 · Johnson & Johnson announced its 61st consecutive dividend increase and it raised its 2023 outlook along with beating top and bottom line estimates. Find out why JNJ stock is a Buy. 31 January, 2023 | Matt Cook. See the most recent Johnson & Johnson (NYSE:JNJ) share price, news, company analysis, and price history from our financial experts.So, let's check out these top dividend stocks to own in 2023. 1. Johnson & Johnson. Johnson & Johnson ( JNJ -0.20%) will pay you $4.52 a share annually just for being a shareholder. That means if ...J&J’s revenue growth of 7.2% over the last twelve months is much better than -1.7% for Medtronic. Even if we look at a longer time frame, J&J’s sales growth has been better. It rose at an ...Some of the best dividend stocks in this regard are The Procter & Gamble Company (NYSE: PG ), Johnson & Johnson (NYSE: JNJ ), and AbbVie Inc. (NYSE: ABBV) which have raised their dividends for ...October 18, 2022. New Brunswick, N.J. (October 18, 2022) – Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2022. “Our third quarter performance demonstrates our continued strength and resilience across all three of our businesses,” said Joaquin Duato, Chief Executive Officer.Feb 7, 2023 · While Coca-cola saw its sales rise at an average annual growth rate of 4.8% to $38.7 billion in 2021, vs. $34.3 billion in 2018, J&J’s saw its revenue grow at an average rate of 5.1% to $94.9 ... May 25, 2022 · If JNJ stock closes above 182.50 on the expiration date, the shares will be called away at 182.50, leaving the trader with a total profit of $385 (gain on the shares plus the $300 option premium ...

Galeanu Mihai/iStock via Getty Images. Thesis. I first wrote about AbbVie Inc. (NYSE:ABBV) back in Aug 2021.At that time, the stock was trading at $114 per share, or only about 8x times its ...If JNJ stock closes above 182.50 on the expiration date, the shares will be called away at 182.50, leaving the trader with a total profit of $385 (gain on the shares plus the $300 option premium ...New Brunswick, N.J. (April 18, 2023) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2023. “Our first quarter results demonstrate strong performance across all three segments of our business and reflect the dedication of Johnson & Johnson colleagues around the world,” said Joaquin Duato, Chairman of the Board …Instagram:https://instagram. paladium stockbrokers outside usdiscovery plus costnasdaq ctxr J&J is a member of an elite group of stocks known as Dividend Kings -- S&P 500 companies that have increased their dividend for at least 50 consecutive years. The healthcare giant recently boosted ... day trading systemsdentalplan.com The current consensus for Johnson & Johnson ( JNJ) implies $10.75 EPS on $100.21B in revenue. JNJ intends to report a ~$20B gain in Q3 2023 in relation to the Kenvue separation and plans to ... best trading bot for crypto J&J is a member of an elite group of stocks known as Dividend Kings -- S&P 500 companies that have increased their dividend for at least 50 consecutive years. The healthcare giant recently boosted ...Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more.